adalimumab antibody fragment in complex with tumor necrosis factor alpha

adalimumab alpha antibody antiinflammatory autoimmune binding binds complex diseases factor factoralpha fragment inflammatory leads medication necrosis receptors reduces response specific this tnf treatment tumor